The	O
modulation	O
of	O
platelet	B-Cell
and	O
endothelial	B-Cell
cell	I-Cell
adhesion	O
to	O
vascular	B-Multi-tissue_structure
graft	I-Multi-tissue_structure
materials	O
by	O
perlecan	O
.	O

Controlled	O
neo	O
-	O
endothelialisation	O
is	O
critical	O
to	O
the	O
patency	O
of	O
small	O
diameter	O
vascular	B-Multi-tissue_structure
grafts	I-Multi-tissue_structure
.	O

Endothelialisation	O
and	O
platelet	B-Cell
adhesion	O
to	O
purified	O
endothelial	B-Cell
cell	I-Cell
-	O
derived	O
perlecan	O
,	O
the	O
major	O
heparan	O
sulfate	O
(	O
HS	O
)	O
proteoglycan	O
in	O
basement	B-Cellular_component
membranes	I-Cellular_component
,	O
were	O
investigated	O
using	O
in	O
vivo	O
and	O
in	O
vitro	O
assays	O
.	O

Expanded	O
polytetrafluoroethylene	O
(	O
ePTFE	O
)	O
vascular	B-Multi-tissue_structure
grafts	I-Multi-tissue_structure
were	O
coated	O
with	O
perlecan	O
and	O
tested	O
in	O
an	O
ovine	O
carotid	B-Multi-tissue_structure
interposition	O
model	O
for	O
a	O
period	O
of	O
6	O
weeks	O
and	O
assessed	O
using	O
light	O
and	O
scanning	O
microscopy	O
.	O

Enhanced	O
endothelial	B-Cell
cell	I-Cell
growth	O
and	O
reduced	O
platelet	B-Cell
adhesion	O
were	O
observed	O
on	O
the	O
perlecan	O
coated	O
grafts	B-Multi-tissue_structure
when	O
compared	O
to	O
uncoated	O
controls	O
implanted	O
in	O
the	O
same	O
sheep	O
(	O
n	O
=	O
5	O
)	O
.	O

Perlecan	O
was	O
also	O
found	O
to	O
stimulate	O
endothelial	B-Cell
cell	I-Cell
proliferation	O
in	O
vitro	O
over	O
a	O
period	O
of	O
6	O
days	O
in	O
the	O
presence	O
of	O
plasma	B-Organism_substance
proteins	O
and	O
fibroblastic	O
growth	O
factor	O
2	O
(	O
FGF	O
-	O
2	O
)	O
,	O
however	O
in	O
the	O
absence	O
of	O
FGF	O
-	O
2	O
endothelial	B-Cell
cell	I-Cell
growth	O
could	O
not	O
be	O
maintained	O
during	O
this	O
period	O
.	O

Perlecan	O
was	O
found	O
to	O
be	O
anti	O
-	O
adhesive	O
for	O
platelets	B-Cell
,	O
however	O
after	O
removal	O
of	O
the	O
HS	O
chains	O
attached	O
to	O
perlecan	O
,	O
platelet	B-Cell
adhesion	O
and	O
aggregation	O
were	O
supported	O
.	O

These	O
results	O
suggest	O
a	O
role	O
for	O
HS	O
chains	O
of	O
perlecan	O
in	O
improving	O
graft	B-Multi-tissue_structure
patency	O
by	O
selectively	O
promoting	O
endothelial	B-Cell
cell	I-Cell
proliferation	O
while	O
modulating	O
platelet	B-Cell
adhesion	O
.	O

